Dr. Reddy's recalls some lots of heartburn drug in U.S
MUMBAI (Reuters) - Generic drugmaker Dr. Reddy's Laboratories Ltd (REDY.NS) is recalling about 58,656 bottles of the heartburn drug lansoprazole in the United States due to a microbial contamination, the U.S. Food and Drug Administration said.
It was classified as a "Class II" recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.
While product recalls are not uncommon, the FDA announcement comes amid a string of quality problems for Indian drug makers.
In a weekly report, the U.S. regulator also announced it was banning imports from Sun Pharmaceutical Industries (SUN.NS) Karkhadi manufacturing plant in Gujarat.
And just last week, the FDA disclosed that products made by Sun Pharma and Ranbaxy Laboratories (RANB.NS) were being recalled.
Dr. Reddy's voluntary recall of lansoprazole delayed release capsules, a generic version of Swiss drugmaker Novartis' (NOVN.VX) drug Prevacid 24 HR, began on January 3, 2014, the FDA said on its website.
A spokesman for Dr. Reddy's was not immediately available to comment.
(Reporting by Zeba Siddiqui; Editing by Edwina Gibbs)
- Tweet this
- Share this
- Digg this
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.
Trending On Reuters
U.S. President Barack Obama watched a dazzling parade of India's military might and cultural diversity on Monday, the second day of a visit trumpeted as a chance to establish a robust strategic partnership between the world's two largest democracies. Full Article
Indian economic growth forecasts pegged back, despite rate cuts: Reuters Poll. Full Article